Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001564590-17-001530
Filing Date
2017-02-14
Accepted
2017-02-14 16:15:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G novn-sc13g.htm SC 13G 53234
  Complete submission text file 0001564590-17-001530.txt   54496
Mailing Address 4222 EMPEROR BLVD SUITE 470 DURHAM NC 27703
Business Address 4222 EMPEROR BLVD SUITE 470 DURHAM NC 27703 919-485-8080
Novan, Inc. (Subject) CIK: 0001467154 (see all company filings)

EIN.: 204427682 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89646 | Film No.: 17609026
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NOVAN, INC. 4222 EMPEROR BOULEVARD, SUITE 200 DURHAM NC 27703
Business Address
Schoenfisch Mark (Filed by) CIK: 0001685109 (see all company filings)

Type: SC 13G